TzioufasAGKapsogeorgouEKMoutsopoulosHM. Pathogenesis of Sjogren's syndrome: what we know and what we should learn. J Autoimmun2012; 39: 4–8.
3.
SkopouliFNDafniUIoannidisJPMoutsopoulosHM. Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome. Semin Arthritis Rheum2000; 29: 296–304.
4.
DimitriouIDKapsogeorgouEKAbu-HeluRFMoutsopoulosHMManoussakisMN. Establishment of a convenient system for the long-term culture and study of non-neoplastic human salivary gland epithelial cells. Eur J Oral Sci2002; 110: 21–30.
5.
MoutsopoulosHMHooksJJChanCCDalavangaYASkopouliFNDetrickB. HLA-DR expression by labial minor salivary gland tissues in Sjogren's syndrome. Ann Rheum Dis1986; 45: 677–683.
6.
ManoussakisMNDimitriouIDKapsogeorgouEK. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjogren's syndrome. Arthritis Rheum1999; 42: 229–239.
7.
KapsogeorgouEKMoutsopoulosHMManoussakisMN. A novel B7-2 (CD86) splice variant with a putative negative regulatory role. J Immunol2008; 180: 3815–3823.
8.
ManoussakisMNKapsogeorgouEK. The role of intrinsic epithelial activation in the pathogenesis of Sjogren's syndrome. J Autoimmun2010; 35: 219–224.
9.
GroomJKalledSLCutlerAHOlsonCWoodcockSASchneiderP. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest2002; 109: 59–68.
10.
SpachidouMPBourazopoulouEMaratheftisCI. Expression of functional Toll-like receptors by salivary gland epithelial cells: increased mRNA expression in cells derived from patients with primary Sjogren's syndrome. Clin Exp Immunol2007; 147: 497–503.
11.
RoutsiasJGTzioufasAG. Autoimmune response and target autoantigens in Sjogren's syndrome. Eur J Clin Invest2010; 40: 1026–1036.
12.
HorsfallACRoseLMMainiRN. Autoantibody synthesis in salivary glands of Sjogren's syndrome patients. J Autoimmun1989; 2: 559–568.
13.
TengnerPHalseAKHagaHJJonssonRWahren-HerleniusM. Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjogren's syndrome. Arthritis Rheum1998; 41: 2238–2248.
14.
HalseAHarleyJBKroneldUJonssonR. Ro/SS-A-reactive B lymphocytes in salivary glands and peripheral blood of patients with Sjogren's syndrome. Clin Exp Immunol1999; 115: 203–207.
15.
CohenJJDukeRCFadokVASellinsKS. Apoptosis and programmed cell death in immunity. Annu Rev Immunol1992; 10: 267–293.
16.
ManganelliPQuainiFAndreoliAM. Quantitative analysis of apoptosis and bcl-2 in Sjogren's syndrome. J Rheumatol1997; 24: 1552–1557.
17.
KongLOgawaNMcGuffHS. Bcl-2 family expression in salivary glands from patients with primary Sjogren's syndrome: involvement of Bax in salivary gland destruction. Clin Immunol Immunopathol1998; 88: 133–141.
18.
OhlssonMSkarsteinKBolstadAIJohannessenACJonssonR. Fas-induced apoptosis is a rare event in Sjogren's syndrome. Lab Invest2001; 81: 95–105.
19.
Abu-HeluRFDimitriouIDKapsogeorgouEKMoutsopoulosHMManoussakisMN. Induction of salivary gland epithelial cell injury in Sjogren's syndrome: in vitro assessment of T cell-derived cytokines and Fas protein expression. J Autoimmun2001; 17: 141–153.
20.
RosenACasciola-RosenLAhearnJ. Novel packages of viral and self-antigens are generated during apoptosis. J Exp Med1995; 181: 1557–1561.
21.
OhlssonMJonssonRBrokstadKA. Subcellular redistribution and surface exposure of the Ro52, Ro60 and La48 autoantigens during apoptosis in human ductal epithelial cells: a possible mechanism in the pathogenesis of Sjogren's syndrome. Scand J Immunol2002; 56: 456–469.
22.
LisiSSistoMLofrumentoD. Regulation of mRNA caspase-8 levels by anti-nuclear autoantibodies. Clin Exp Med2009; 10: 199–203.
KapsogeorgouEKAbu-HeluRFMoutsopoulosHMManoussakisMN. Salivary gland epithelial cell exosomes: a source of autoantigenic ribonucleoproteins. Arthritis Rheum2005; 52: 1517–1521.
26.
EllisRJ. Molecular chaperones: assisting assembly in addition to folding. Trends Biochem Sci2006; 31: 395–401.
27.
LiZMenoretASrivastavaP. Roles of heat-shock proteins in antigen presentation and cross-presentation. Curr Opin Immunol2002; 14: 45–51.
28.
StaikouEVRoutsiasJGMakriAA. Calreticulin binds preferentially with B cell linear epitopes of Ro60 kD autoantigen, enhancing recognition by anti-Ro60 kD autoantibodies. Clin Exp Immunol2003; 134: 143–150.
29.
BasuSBinderRJRamalingamTSrivastavaPK. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity2001; 14: 303–313.
